
The Take: It’s Time to Embrace a Hybrid Model of Patient Care
Avita’s Glen Pietrandoni and Lee Horner offer no-holds-barred insights on the intersection of telehealth and onsite care in this edition of “The Take.”
We respect you as an individual and treat you like family. Our deep expertise and personal service ensure your care matches your lifestyle.
Our proven experience working with 340B covered entity partners allows us to tailor our services and solutions to best fit your business.
Avita’s Glen Pietrandoni and Lee Horner offer no-holds-barred insights on the intersection of telehealth and onsite care in this edition of “The Take.”
A lack of strategic marketing can keep a covered entity from fulfilling its mission. Avita’s Glen Pietrandoni & Liz Eckert offer five tips for engaging patients.
What’s behind Avita’s recent expansion and brand refresh? It’s all about helping patients and partners remove barriers to care, CEO Michael Yount explains.
Alleviating the massive health equity crisis will take innovative thinking from across the industry. Avita’s Michael Yount and Dr. Joel Rosenstock discuss why.
Avita’s growth into a health care services organization reinforces our dedication to reducing health inequities. Here’s how.
Dr. Eugene McCray has been at the forefront of the fight to end HIV/AIDS since its inception. Here’s what he’s learned along the way.
Ensuring the true value of the 340B program is fully understood has never been more critical. Here’s why and how covered entities can easily get involved.
The 30-year champion of HIV prevention and treatment, LGBTQ+ rights, and the 340B program will lead the next chapter of Avita’s advocacy efforts.
At the 340B Coalition Summer Conference, Avita Board Member Dr. Jerome Adams offered advice on supporting the drug discount program’s future. Read on for insights from 340B Report.
As PrEP turns 10, advocate Jim Pickett discusses the early years and what’s coming next. “We’ve come a long way, baby. But there’s so much work to do.”
Confused by the latest 340B program developments? In this edition of The Take, Ted Slafsky breaks down current events & predicts what’s next.
Covered entities depend on 340B funding to serve vulnerable patients. Here are 7 insights on how to successfully navigate the program during challenging times.
The 340B Program was created to fund vital services for some of America’s most vulnerable patients. Amidst all the controversy, that sometimes gets forgotten.
The landscape for covered entities is changing quickly, and both the future of your business and the wellness of your patients is on the line.
Introducing The Avita Blog! Here’s what to expect as we strive to provide actionable insights that help the community learn and grow together.
Our mission is to provide individually focused pharmacy services, support, and advocacy for our patients and partners.